Align Technology (ALGN) Q3 2024: Systems & Services Revenue Jumps 16%, Offsetting U.S. Ortho Weakness

October 23, 2024 | By EarningsIQ Research

Align posted mixed Q3 results as international clear aligner growth and a 16% surge in systems and services revenue countered persistent U.S. dental market softness. The company accelerated restructuring and shifted capital allocation to protect margins and fund next-gen digital orthodontics, signaling a more mature, margin-focused operating model for 2025. Management’s outlook remains cautious on U.S. demand but confident in technology innovation and international expansion as primary growth levers.

Summary

• International Demand Drives Resilience: Strong APAC and EMEA clear aligner growth and record teen case starts offset U.S. market drag.
• Margin Focus Amid Restructuring: Cost actions and portfolio prioritization support margin expansion and next-gen technology investment.
• 2025 Setup Hinges on Macro: Execution pivots to innovation and efficiency while U.S. dental demand remains the key swing factor.

Business Overview

Align Technology, maker of Invisalign clear aligners and iTero digital scanners, generates revenue through orthodontic and dental solutions sold to dental professionals worldwide. The business is organized into two segments: Clear Aligners (Invisalign, Vivera retainers, and related programs) and Systems and Services (iTero intraoral scanners, software, and support services). The company’s growth depends on global orthodontic procedure adoption, digital workflow penetration, and its leadership in clear aligner technology.

Performance Analysis

Q3 revenue grew modestly year-over-year, with systems and services revenue up 15.6%—a standout driven by higher scanner average selling prices (ASPs), software upgrades, and flexible leasing programs. Clear aligner volumes increased globally, led by APAC (notably China), EMEA, and Latin America, but U.S. volumes declined as dental demand remained weak. Gross margin held steady year-over-year, aided by product mix and manufacturing efficiencies, despite FX and regional pricing headwinds.

Operating expenses fell sequentially, reflecting lower legal, advertising, and compensation costs, but rose year-over-year due to wage inflation and restructuring. The company delivered strong free cash flow, supported by disciplined capital expenditures and working capital management. Deferred revenue declined in both segments, reflecting shorter contract durations and more upfront revenue recognition from new product offerings.

• Systems & Services Outperformance: 16% YoY revenue growth in scanners and services, driven by iTero Lumina adoption and expanded rental/leasing.
• International Clear Aligner Strength: APAC and EMEA led clear aligner volume growth, with China setting records for teen case starts.
• U.S. Dental Market Drag: Persistent U.S. demand softness weighed on overall clear aligner volumes and ASPs, offsetting global gains.

Management’s focus on international growth, product innovation, and cost control helped balance the impact of U.S. market weakness, setting the stage for a more resilient margin profile into 2025.

Executive Commentary

Strategic Positioning

1. International Expansion and Segment Diversification

Align’s fastest growth is now international, with APAC and EMEA clear aligner volumes offsetting U.S. declines. Record teen case starts in China and strong Latin America performance demonstrate the company’s ability to diversify revenue streams and reduce reliance on any single market. Regional product launches, such as the Invisalign Pallet Expander in Asia, further support this pivot.

2. Systems and Services as a Growth Engine

Systems and Services, anchored by iTero Lumina, is increasingly central to Align’s growth and margin profile. The segment benefits from higher ASPs, new software workflows, and flexible rental/leasing models, which generate recurring revenue and deepen customer engagement. This business now provides a counter-cyclical buffer against clear aligner demand swings.

3. Portfolio Prioritization and Restructuring

Align is restructuring operations—eliminating roughly 700 positions—to reallocate resources toward high-ROI innovation and margin expansion. The company is prioritizing investments in 3D printing, five-minute ClinCheck (treatment planning software), and next-gen scanner platforms, while pulling back on lower-return projects and U.S.-centric initiatives.

4. Consumer Financing and Brand Leverage

Recognizing consumer affordability as a constraint, Align is piloting new financing initiatives and leveraging its brand through selective retail partnerships (e.g., Costco) to stimulate demand. While not yet material, these efforts reflect a broader push to lower barriers to treatment and capture latent demand, especially as economic uncertainty weighs on discretionary dental spending.

5. Technology Leadership and Product Pipeline

Align’s commitment to digital orthodontics is evident in its ongoing investments in direct 3D printing, next-gen intraoral scanners, and treatment simulation software. These innovations aim to improve clinical outcomes, speed, and patient experience, reinforcing Align’s competitive moat and enabling margin accretion as adoption scales.

Key Considerations

This quarter’s results highlight a decisive shift in Align’s operating model, emphasizing international growth, efficiency, and technology leadership to offset persistent U.S. market headwinds.

Key Considerations:

• International Growth Outpaces U.S.: APAC and EMEA clear aligner demand and systems sales are now the primary growth drivers, reducing U.S. dependency.
• Restructuring Unlocks Margin and Innovation: Workforce reductions and portfolio focus create margin headroom and fund next-gen technology even as near-term growth slows.
• Systems and Services Provide Resilience: Recurring scanner and software revenue help stabilize results when clear aligner volumes fluctuate.
• Consumer Financing and Brand Strategies Are Early-Stage: Efforts to stimulate U.S. demand via financing and retail partnerships are not yet significant but could become more material if macro improves.
• Product Pipeline and Digital Workflow Remain Core: Direct 3D printing and software innovation are positioned as the foundation for the next growth cycle, with scaling benefits expected over the next two to three years.

Risks

U.S. dental demand remains the primary risk, with consumer confidence, discretionary spending, and patient traffic all cited as headwinds by both management and doctor customers. FX volatility, regulatory changes (such as UK VAT), and initial margin dilution from scaling 3D printing could pressure results. Competitive intensity is stable, but any acceleration in alternative clear aligner offerings or new dental technologies could impact share. Restructuring and cost actions must be executed carefully to avoid disrupting innovation or customer relationships.

Forward Outlook

For Q4 2024, Align guided to:

• Worldwide revenue of $995 million to $1.015 billion
• Sequentially higher clear aligner volume and ASPs
• Systems and services revenue up sequentially, in line with typical Q4 seasonality
• GAAP operating margin slightly below 14% due to restructuring charges (impacting margin by ~3 points)
• Non-GAAP operating margin slightly up sequentially

For full-year 2024, management expects:

• Capital expenditures above $100 million, focused on manufacturing and facility expansion

Management emphasized that margin accretion is expected in 2025 despite initial costs from scaling direct 3D printing, and reiterated that macroeconomic conditions—especially in the U.S.—will be the key determinant of top-line acceleration.

• International momentum and new product launches to drive growth
• Restructuring to support both innovation and margin expansion in 2025

Takeaways

Align is evolving into a more diversified and margin-focused business, with international demand and systems revenue providing ballast against U.S. headwinds.

• Resilient Margin Profile: Cost actions and segment diversification position Align for margin accretion even in a sluggish U.S. market.
• Innovation as Growth Catalyst: Investments in 3D printing, software, and scanner technology are prioritized to drive the next growth cycle.
• Macro Remains the Wildcard: U.S. dental demand and consumer confidence will dictate the pace of top-line recovery and the magnitude of upside from new initiatives.

Conclusion

Align’s Q3 results underscore a business in transition—balancing near-term market challenges with strategic investments in technology and geography diversification. The company’s margin discipline and innovation roadmap position it for long-term leadership, but the timing and scale of recovery hinge on macroeconomic improvement, particularly in the U.S.

Industry Read-Through

Align’s performance and commentary reinforce a broader theme in dental and medtech: international markets and services are outpacing U.S. procedure growth as macro headwinds persist domestically. Capital equipment providers with recurring revenue streams (leasing, software) are better insulated from demand volatility. Digital workflow adoption and next-gen technologies (like 3D printing) remain the sector’s primary long-term growth levers, but require upfront investment and margin patience. U.S. dental market softness—especially in adult discretionary procedures—remains a key risk for the industry, with consumer financing and patient traffic as watchpoints for future quarters.

ALGN Healthcare Medical Devices Digital Dentistry Orthodontics International Growth Restructuring 3D Printing